Comparison of early and late start of antihypertensive agents and baroreceptor reflexes

Hypertension

Volumn 27, Issue 2, 1996, Pages 209-218

  Kumagai, Kazuhiro ^a   Suzuki, Hiromichi ^a   Ichikawa, Masashi ^a   Jimbo, Masahito ^a   Nishizawa, Masahiko ^a   Ryuzaki, Munekazu ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

angiotensin converting enzyme inhibitors; baroreflex; calcium channel blockers; diuretics; rats, inbred SHR; receptors, adrenergic, beta

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; ENALAPRIL MALEATE; GLYCERYL TRINITRATE; NICARDIPINE; PHENYLEPHRINE; TRICHLORMETHIAZIDE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; HEART RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE;

EID: 0030027928     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.2.209     Document Type: Article

References (44)

1. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med. 1991;151:1413-1423.
2. Kumagai K, Suzuki H, Ryuzaki M, Kumagai H, Ichikawa M, Jimbo M, Matsumura Y, Saruta T. Effects of antihypertensive agents on arterial baroreceptor reflexes in conscious rats. Hypertension. 1992;20:701-709.
3. Wu J-N, Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1993;22:139-146.
4. Kumagai K, Suzuki H, Ichikawa M, Jimbo M, Murakami M, Ryuzaki M, Saruta T. Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension. 1994;24:220-226.
5. Kumagai K, Reid IA. Angiotensin II exerts differential actions on renal nerve activity and heart rate. Hypertension. 1994;24:451-456.
6. Farnett L, Mulrow CD, Linn WD, Luckey CR, Tuley MR. The J-curve phenomenon and treatment of hypertension: is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-495.
7. Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983;221:869-871.
8. Cheng SWT, Kirk KA, Robertson JD, Berecek KH. Brain angiotensin II and baroreceptor reflex function in spontaneously hypertensive rats. Hypertension. 1989;14:274-281.
9. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive therapy on mechanics of cerebral arteries in rats. Hypertension. 1991;17:308-316.
10. Pickering TG, Gribbin B, Peterson ES, Cunningham DJC, Sleight P. Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res. 1972;30:177-185.
11. Takeshita A, Tanaka S, Nakamura M. Effects of propranolol on baroreflex sensitivity in borderline hypertension. Cardiovasc Res. 1978;12:148-151.
12. Simon G, Kiowski W, Julius S. Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther. 1977;22:293-298.
13. Krediet RT, Dunning AJ. Baroreflex sensitivity in hypertension during beta-adrenergic blockade. Br Heart J. 1979;41:106-110.
14. Watson RDS, Stallard TJ, Littler WA. Effects of β-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man. Clin Sci. 1979;57:241-247.
15. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993;21:886-893.
16. Goldstein DS. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation. 1983;68:234-240.
17. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
18. Purdy RE, Weber MA. Angiotensin II amplification of α-adrenergic vasoconstriction: role of receptor reserve. Circ Res. 1988;63:748-757.
19. Vanhoutte PM, Verbeuren TJ, Webb C. Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev. 1981;61:151-247.
20. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens. 1984;2:581-587.
21. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262:E763-E778.
22. Kumagai K, Reid IA. Losartan inhibits sympathetic and cardiovascular responses to carotid occlusion. Hypertension. 1994;23(pt 2):827-831.
23. Cook JR, Thomas Bigger J Jr, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol. 1991;17:480-484.
24. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol. 1979;294:69-80.
25. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1701-1714.
26. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
27. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med. 1987;316:1429-1435.
28. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence for a selective increase in resting cardiac sympathetic activity in some patients suffering sustained out of hospital ventricular arrhythmias. N Engl J Med. 1991;325:618-624.
29. Cohn J, Levine T, Oliver M, Garberg V, Tuna D, Francis G, Simon A, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
30. Takeshita A, Matsuguchi H, Nakamura M. Effect of coronary occlusion on arterial baroreflex control of heart rate. Cardiovasc Res. 1980;14:303-306.
31. Billman GE, Schwartz PJ, Stone HL. Baroreccptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation. 1982;66:874-880.
32. Fleckenstein A, Fleckenstein G, Frey M, Zorn J. Calcium antagonism and ACE inhibitor: two outstandingly effective means of interference with cardiovascular calcium overload, high blood pressure, and arteriosclerosis in spontaneously hypertensive rats. Am J Hypertens. 1989;2:194-204.
33. Triggle CR, Laher I. A review of changes in vascular smooth muscle functions in hypertension: isolated tissue versus in vivo studies. Can J Physiol Pharmacol. 1985;63:355-365.
34. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Circ Res. 1982;51:280-289.
35. Folkow B. Vascular changes in hypertension: therapeutic implications. Drugs. 1985;29(suppl 2):1-8.
36. Folkow B. 'Structural factor' in primary and secondary hypertension. Hypertension. 1990;16:89-101.
37. Koushanpour E. Baroreceptor discharge behavior and resetting. In: Persson PB, Kirchheim HR, eds. Baroreceptor Reflexes: Integrative Functions and Clinical Aspects. Berlin, FRG: Springer-Verlag; 1991:9-44.
38. Sumitani M, Krieger EM. Regression of the baroreceptor resetting in hypertension of long duration in rats. Clin Sci. 1981;61:185s-186s.
39. Ichikawa M, Suzuki H, Kumagai K, Kumagai H, Ryuzaki M, Nishizawa M, Saruta T. Differential modulation of baroreceptor sensitivity by long-term antihypertensive treatment. Hypertension. 1995;26:425-431.
40. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(suppl III):III-115-III-121.
41. Chapleau MW, Hajduczok G, Abboud FM. Peripheral and central mechanisms of baroreflex resetting. Clin Exp Pharmacol Physiol. 1989;15(suppl):31-43.
42. Andresen MC, Krauhs JM, Brown AM. Relationship of aortic wall and baroreceptor properties during development in normotensive and spontaneously hypertensive rats. Circ Res. 1978;43:728-738.
43. Krauhs JM. Structure of rat aortic baroreceptors and their relationship to connective tissue. J Neurocytol. 1979;8:401-414.
44. Sapru HN, Wang SC. Modification of aortic baroreceptor resetting in the spontaneously hypertensive rat. Am J Physiol. 1976;230:664-674.